Position in JNJ
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,878,108
+$437,135 QoQ
Shares Held
7,395
+25.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#2,410
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Providence Capital Advisors, LLC holds $29,086,080 across 11 Drug Manufacturers - General names. JNJ ranks #7 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
|
32,898 | $5,155,774 | |
| 2 | ABBV |
AbbVie Inc.
|
18,952 | $4,769,081 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
82,081 | $4,729,507 | |
| 4 | PFE |
Pfizer Inc
|
168,652 | $4,061,140 | |
| 5 | MRK |
Merck & Co., Inc.
|
30,948 | $3,976,818 | |
| 6 | SNY |
Sanofi
|
85,773 | $3,659,076 | |
| 7 | JNJ |
Johnson & Johnson
This page
|
7,395 | $1,878,108 | |
| 8 | LLY |
ELI LILLY & Co
|
602 | $722,056 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,878,108 | 7,395 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,440,973 | 5,895 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,271,707 | 6,145 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,130,134 | 6,095 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $932,691 | 6,106 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $487,569 | 2,940 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $425,038 | 2,939 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $503,844 | 3,109 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $5,979,259 | 40,909 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $5,759,539 | 36,409 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $501,724 | 3,201 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $481,734 | 3,093 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $505,001 | 3,051 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $4,750,905 | 30,651 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $590,717 | 3,344 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $4,620,964 | 28,287 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $579,925 | 3,267 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $609,139 | 3,437 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $580,782 | 3,395 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $577,524 | 3,576 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $539,194 | 3,273 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $438,485 | 2,668 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $381,961 | 2,427 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $379,346 | 2,548 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $358,325 | 2,548 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $379,883 | 2,897 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||